Todd Wider is Director at ABEONA THERAPEUTICS INC. (ABEO). They have made 10 open-market trades across 2 companies since 2015, most recently 2026-06-30.
CIK 0001642715
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
3 open-market purchases totalling $320K since 2015, against 7 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| ASPI | 672,247 | $1.4M |
| ABEO | 16,907 | $75K |
| Total | $1.5M |
Shares reported on the most recent Form 4, priced at the 2026-07-01 close.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| ASPI | SELL | 2026-06-29 | 2026-07-01 | $6.19 | $619K | -23.6% | -35.3% | -57.3% |
| ASPI | SELL | 2025-09-15 | 2025-10-03 | $8.76 | $1.3M | +33.5% | -3.2% | -40.4% |
| ASPI | BUY | 2023-10-26 | 2023-10-30 | $0.96 | $182K | +1.8% | +65.8% | +111.7% |
| ABEO | SELL | 2021-10-07 | 2021-10-08 | $0.97 | $24K | -6.5% | +0.7% | -67.3% |
| ABEO | SELL | 2021-02-19 | 2021-02-23 | $2.39 | $1.2M | -6.5% | -12.6% | -27.9% |
| ABEO | SELL | 2021-02-17 | 2021-02-19 | $2.34 | $752K | -7.2% | -13.6% | -33.5% |
| ABEO | SELL | 2021-01-04 | 2021-01-05 | $1.54 | $104K | +7.8% | +38.8% | +4.4% |
| ABEO | SELL | 2020-12-02 | 2020-12-02 | $1.49 | $101K | -0.6% | +8.3% | +51.3% |
| ABEO | SELL · 10b5-1 | 2020-11-23 | 2020-11-24 | $1.33 | $24K | +7.1% | +23.6% | +59.3% |
| ABEO | SELL · 10b5-1 | 2020-11-02 | 2020-11-06 | $1.04 | $35K | +29.6% | +38.9% | +127.8% |
| ABEO | BUY | 2016-09-20 | 2016-09-28 | $5.48 | $27K | +11.5% | +14.6% | -15.4% |
| ABEO | BUY | 2015-07-31 | 2015-08-03 | $5.50 | $110K | -24.0% | +4.0% | +4.0% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.